Brief: Masonic Cancer Center, University Of Minnesota To Present Phase 1 Clinical Trial Data For Hcw9218 In Solid Tumors

Hcw Biologics

08/11/2022 12:46

Nov 8 (Reuters) - HCW Biologics Inc  HCWB.O :
    * MASONIC CANCER CENTER, UNIVERSITY OF MINNESOTA TO PRESENT
DATA
IN POSTER PRESENTATION FROM THE PHASE 1 CLINICAL TRIAL TO
EVALUATE HCW9218 IN SOLID TUMORS AT THE SITC 37TH ANNUAL MEETING

Source text for Eikon:  ID:nGNX35t9Cw 
Further company coverage:  HCWB.O 
 ((Reuters.Briefs@thomsonreuters.com;))